Brief: Takeda's Orzeyful Available In U.S. By Prescription To Treat Narcolepsy Type 1 In Adults
Yesterday 12:30
BRIEF-Takeda's Orzeyful Available In U.S. By Prescription To Treat Narcolepsy Type 1 In Adults Nov 12 (Reuters) - Takeda Pharmaceutical Company Limited 4502.T:
TAKEDA: ORZEYFUL CIV NOW AVAILABLE IN U.S. BY PRESCRIPTION FOR TREATMENT OF NARCOLEPSY TYPE 1 IN ADULTS
TAKEDA: U.S. WHOLESALE ACQUISITION COST FOR ORZEYFUL $16,500 PER 60-TABLET BOTTLE, WITH SAME PRICE ACROSS ALL THREE STRENGTHS
Further company coverage: 4502.T
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Takeda Pharmaceutical
See all newsTakeda launches sleep disorder pill in the US after DEA clearance removes final hurdle (updated)
Brief: Takeda's Orzeyful Available In U.S. By Prescription To Treat Narcolepsy Type 1 In Adults
Takeda launches sleep disorder pill in the US after DEA clearance removes final hurdle
Takeda Pharmaceutical Company Limited reports results for the quarter ended September 30 - Earnings Summary
Table: Takeda Pharmaceutical Company Limited -6-MTH group results (IFRS)